Adial Pharmaceuticals
ADIL
#10837
Rank
C$19.01 M
Marketcap
C$7.24
Share price
36.12%
Change (1 day)
1,611.86%
Change (1 year)

EPS for Adial Pharmaceuticals (ADIL)

EPS in 2026 (TTM): C-$27.10

According to Adial Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$27.73. In 2025 the company made an earnings per share (EPS) of C-$17.11 an increase over its 2024 EPS that were of C-$97.53.

EPS history for Adial Pharmaceuticals from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$27.1058.38%
2025C-$17.11-82.46%
2024C-$97.53-24.43%
2023C-$129.06-71.68%
2022C-$455.65-51.12%
2021C-$932.1019.54%
2020C-$779.74-0%
2019C-$779.74-64.34%
2018C-$2,1871072.27%
2017C-$186.55136.68%
2016C-$78.82-56.33%
2015C-$180.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
C-$0.08604-99.69% Bahamas
NRC Health
NRC
C$0.42-101.50%๐Ÿ‡บ๐Ÿ‡ธ USA